Skip to main content
Erschienen in: Rheumatology International 8/2012

01.08.2012 | Original Article

The correlation between durometer score and modified Rodnan skin score in systemic sclerosis

verfasst von: Ki Won Moon, Ran Song, Jin Hyun Kim, Eun Young Lee, Eun Bong Lee, Yeong Wook Song

Erschienen in: Rheumatology International | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

The aims of the present study were to determine the correlation between durometer scores with modified Rodnan skin scores (MRSS), scleroderma symptoms, and physical functions. A total of 31 patients with systemic sclerosis (SSc, 16 diffuse and 15 limited type) were enrolled in this study. Skin involvement was measured using a durometer and MRSS. Health assessment questionnaire (HAQ) disability indices, Keitel function test (KTF) scores, grip strengths, and scleroderma-visual analog scale (scleroderma-VAS) scores were measured. The correlations between durometer scores with MRSS, HAQ disability indices, and scleroderma-VAS scores were assessed. Durometer scores correlated well with MRSS at fingers, hands, forearms, upper arms, thighs, and feet, but poorly correlated with MRSS at the chest, abdomen, and lower legs. Total durometer scores correlated well with MRSS (r = 0.537, P = 0.002) and KTF scores (r = 0.608, P < 0.001), but poorly correlated with HAQ disability indices (r = 0.202, P = 0.276), and individual scleroderma-VAS scores. Durometer-measured skin hardnesses were found to correlate well with the MRSS scores of fingers, hands, forearms, upper arms, thighs, and feet. The authors suggest that these skin sites should be included when durometer measurements are made in systemic sclerosis.
Literatur
1.
Zurück zum Zitat Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA Jr, Steen VD, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Furst DE (2000) Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 43(11):2445–2454. doi:10.1002/1529-0131(200011)43:11<2445:AID-ANR11>3.0.CO;2-Q PubMedCrossRef Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA Jr, Steen VD, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Furst DE (2000) Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 43(11):2445–2454. doi:10.​1002/​1529-0131(200011)43:​11<2445:​AID-ANR11>3.​0.​CO;2-Q PubMedCrossRef
2.
Zurück zum Zitat Khanna D, Merkel PA (2007) Outcome measures in systemic sclerosis: an update on instruments and current research. Curr Rheumatol Rep 9(2):151–157PubMedCrossRef Khanna D, Merkel PA (2007) Outcome measures in systemic sclerosis: an update on instruments and current research. Curr Rheumatol Rep 9(2):151–157PubMedCrossRef
3.
Zurück zum Zitat Furst D, Khanna D, Matucci-Cerinic M, Clements P, Steen V, Pope J, Merkel P, Foeldvari I, Seibold J, Pittrow D, Polisson R, Strand V (2007) Systemic sclerosis—continuing progress in developing clinical measures of response. J Rheumatol 34(5):1194–1200. doi:0315162X-34-1194 PubMed Furst D, Khanna D, Matucci-Cerinic M, Clements P, Steen V, Pope J, Merkel P, Foeldvari I, Seibold J, Pittrow D, Polisson R, Strand V (2007) Systemic sclerosis—continuing progress in developing clinical measures of response. J Rheumatol 34(5):1194–1200. doi:0315162X-34-1194 PubMed
4.
Zurück zum Zitat Czirjak L, Nagy Z, Aringer M, Riemekasten G, Matucci-Cerinic M, Furst DE (2007) The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis 66(7):966–969. doi:10.1136/ard.2006.066530 PubMedCrossRef Czirjak L, Nagy Z, Aringer M, Riemekasten G, Matucci-Cerinic M, Furst DE (2007) The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis 66(7):966–969. doi:10.​1136/​ard.​2006.​066530 PubMedCrossRef
5.
Zurück zum Zitat Ionescu R, Rednic S, Damjanov N, Varju C, Nagy Z, Minier T, Czirjak L Repeated teaching courses of the modified Rodnan skin score in systemic sclerosis. Clin Exp Rheumatol 28 (2 Suppl 58):S37–S41 Ionescu R, Rednic S, Damjanov N, Varju C, Nagy Z, Minier T, Czirjak L Repeated teaching courses of the modified Rodnan skin score in systemic sclerosis. Clin Exp Rheumatol 28 (2 Suppl 58):S37–S41
6.
Zurück zum Zitat Rodnan GP, Lipinski E, Luksick J (1979) Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 22(2):130–140PubMedCrossRef Rodnan GP, Lipinski E, Luksick J (1979) Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 22(2):130–140PubMedCrossRef
8.
Zurück zum Zitat Dugar M, Woolford R, Ahern MJ, Smith MD, Roberts-Thomson PJ (2009) Use of electronic tonometer to assess skin hardness in systemic sclerosis: a pilot cross-sectional study. Clin Exp Rheumatol 27 (3 Suppl 54):70 Dugar M, Woolford R, Ahern MJ, Smith MD, Roberts-Thomson PJ (2009) Use of electronic tonometer to assess skin hardness in systemic sclerosis: a pilot cross-sectional study. Clin Exp Rheumatol 27 (3 Suppl 54):70
9.
Zurück zum Zitat Enomoto DN, Mekkes JR, Bossuyt PM, Hoekzema R, Bos JD (1996) Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma. J Am Acad Dermatol 35 (3 Pt 1):381–387 Enomoto DN, Mekkes JR, Bossuyt PM, Hoekzema R, Bos JD (1996) Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma. J Am Acad Dermatol 35 (3 Pt 1):381–387
10.
Zurück zum Zitat Falanga V, Bucalo B (1993) Use of a durometer to assess skin hardness. J Am Acad Dermatol 29(1):47–51PubMedCrossRef Falanga V, Bucalo B (1993) Use of a durometer to assess skin hardness. J Am Acad Dermatol 29(1):47–51PubMedCrossRef
11.
Zurück zum Zitat Kissin EY, Schiller AM, Gelbard RB, Anderson JJ, Falanga V, Simms RW, Korn JH, Merkel PA (2006) Durometry for the assessment of skin disease in systemic sclerosis. Arthritis Rheum 55(4):603–609. doi:10.1002/art.22093 PubMedCrossRef Kissin EY, Schiller AM, Gelbard RB, Anderson JJ, Falanga V, Simms RW, Korn JH, Merkel PA (2006) Durometry for the assessment of skin disease in systemic sclerosis. Arthritis Rheum 55(4):603–609. doi:10.​1002/​art.​22093 PubMedCrossRef
12.
Zurück zum Zitat Merkel PA, Silliman NP, Denton CP, Furst DE, Khanna D, Emery P, Hsu VM, Streisand JB, Polisson RP, Akesson A, Coppock J, van den Hoogen F, Herrick A, Mayes MD, Veale D, Seibold JR, Black CM, Korn JH (2008) Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial. Arthritis Rheum 59(5):699–705. doi:10.1002/art.23564 PubMedCrossRef Merkel PA, Silliman NP, Denton CP, Furst DE, Khanna D, Emery P, Hsu VM, Streisand JB, Polisson RP, Akesson A, Coppock J, van den Hoogen F, Herrick A, Mayes MD, Veale D, Seibold JR, Black CM, Korn JH (2008) Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial. Arthritis Rheum 59(5):699–705. doi:10.​1002/​art.​23564 PubMedCrossRef
13.
Zurück zum Zitat Masi AT (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic, Therapeutic Criteria Committee. Arthritis Rheum 23(5):581–590CrossRef Masi AT (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic, Therapeutic Criteria Committee. Arthritis Rheum 23(5):581–590CrossRef
14.
Zurück zum Zitat Poole JL, Steen VD (1991) The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 4(1):27–31PubMedCrossRef Poole JL, Steen VD (1991) The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 4(1):27–31PubMedCrossRef
15.
Zurück zum Zitat Poole JL, Cordova KJ, Brower LM (2006) Reliability and validity of a self-report of hand function in persons with rheumatoid arthritis. J Hand Ther 19(1):12–16, quiz 17. doi:10.1197/j.jht.2005.10.001 Poole JL, Cordova KJ, Brower LM (2006) Reliability and validity of a self-report of hand function in persons with rheumatoid arthritis. J Hand Ther 19(1):12–16, quiz 17. doi:10.​1197/​j.​jht.​2005.​10.​001
17.
Zurück zum Zitat Hyde S (1980) Physiotherapy in rheumatology. Blackwell, Oxford Hyde S (1980) Physiotherapy in rheumatology. Blackwell, Oxford
18.
Zurück zum Zitat Belyaev O, Herden H, Meier JJ, Muller CA, Seelig MH, Herzog T, Tannapfel A, Schmidt WE, Uhl W (2010) Assessment of pancreatic hardness-surgeon versus durometer. J Surg Res 158 (1):53–60. doi:10.1016/j.jss.2008.08.022 Belyaev O, Herden H, Meier JJ, Muller CA, Seelig MH, Herzog T, Tannapfel A, Schmidt WE, Uhl W (2010) Assessment of pancreatic hardness-surgeon versus durometer. J Surg Res 158 (1):53–60. doi:10.​1016/​j.​jss.​2008.​08.​022
20.
Zurück zum Zitat Eleni PN, Krokida MK, Polyzois GL, Gettleman L (2009) Material properties of a maxillofacial chlorinated polyethylene elastomer stored in simulated skin secretions. J Biomed Mater Res B Appl Biomater 91(2):964–974. doi:10.1002/jbm.b.31482 PubMed Eleni PN, Krokida MK, Polyzois GL, Gettleman L (2009) Material properties of a maxillofacial chlorinated polyethylene elastomer stored in simulated skin secretions. J Biomed Mater Res B Appl Biomater 91(2):964–974. doi:10.​1002/​jbm.​b.​31482 PubMed
21.
Zurück zum Zitat Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA Jr (2007) Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum 56(8):2740–2746. doi:10.1002/art.22747 PubMedCrossRef Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA Jr (2007) Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum 56(8):2740–2746. doi:10.​1002/​art.​22747 PubMedCrossRef
22.
Zurück zum Zitat Steen VD, Medsger TA Jr (2001) Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 44(12):2828–2835PubMedCrossRef Steen VD, Medsger TA Jr (2001) Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 44(12):2828–2835PubMedCrossRef
Metadaten
Titel
The correlation between durometer score and modified Rodnan skin score in systemic sclerosis
verfasst von
Ki Won Moon
Ran Song
Jin Hyun Kim
Eun Young Lee
Eun Bong Lee
Yeong Wook Song
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 8/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1993-9

Weitere Artikel der Ausgabe 8/2012

Rheumatology International 8/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.